Use of rapid molecular test for multidrug-resistant tuberculosis detection among relapse cases in Cote d'Ivoire

International Journal of Mycobacteriology
K N'guessanM Dosso

Abstract

Tuberculosis is explicitly recognized as a major global public health problem. In Côte d'Ivoire, relapse cases represent 66.5% of patients eligible for retreatment according to the National Tuberculosis Control Program. This study objective was to detect multidrug-resistance tuberculosis among relapse cases. Patients were recruited in tuberculosis centers in routine. A standardized questioning was administrated. Two sputum samples were collected and transported at Institut Pasteur. Sputum samples were decontaminated by NALC method. The DNA extraction was realized with 500μl of decontaminated sputum sample with smear-positive. MTBDRplus assay version 2.0 was performed according to the manufacturer's instruction. An internal quality control program with positive and negative controls was implemented for interpretation of results. In total 146 relapse cases with smear positive were studied. Out of selected patients, 130 had received the 2RHZE/4RH regimen and 16, the 2RHZES/1RHZE/5HRE. In group of relapse cases previously treated with 2RHZE/4RH regimen, 40 (31.3%, IC95%: [0.23; 0.39]) had punctual mutations at codon 526 in rpoB gene. Although, in patients under treated with 2RHZES/1RHZE/5HRE, a mutation in rpoB gene was identified ...Continue Reading

References

Apr 4, 2002·The Journal of Infectious Diseases·Christopher DyeBrian G Williams
Oct 13, 2004·American Journal of Respiratory and Critical Care Medicine·Robert M JasmerUNKNOWN Tuberculosis Trials Consortium
Oct 14, 2008·The Journal of Infectious Diseases·Jason R AndrewsUNKNOWN Tugela Ferry Care and Research Collaboration
Mar 2, 2010·BMC Infectious Diseases·Heidi AlbertRichard O'Brien
Aug 20, 2010·Journal of Clinical Microbiology·Padmapriya P BanadaDavid Alland
Oct 23, 2012·American Journal of Respiratory and Critical Care Medicine·Marinus BarnardRichard O'Brien

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.